Australian Investors Can Ride the US Tech Wave with Betashares Nasdaq 100 ETF

The Betashares Nasdaq 100 ETF tracks the Nasdaq 100 Index, providing exposure to leading US technology and growth companies. With a high concentration of tech stocks, the ETF has delivered double-digit annualized returns over the past decade. It is a good option for investors seeking long-term growth and global innovation.

The Nasdaq 100 index saw significant movements in early trading on July 2, 2025, with notable performances from key players. Regeneron Pharmaceuticals (NASDAQ:REGN) led the index with a 3.6% gain, while Marvell Technology (NASDAQ:MRVL) was the worst performer, declining by 6.7% [1]. Amazon (NASDAQ:AMZN) also saw a significant drop of 6.6%, while Mondelez International (NASDAQ:MDLZ) moved up by 1.8%.

Regeneron Pharmaceuticals' positive performance is notable, especially given its year-to-date (YTD) decline of 20.7%. The biopharmaceutical company reported quarterly adjusted earnings of $12.89 per share for the quarter ended June 30, 2025, which exceeded the mean expectation of $8.44 per share [2]. The company also reported a 3.6% increase in revenue to $3.68 billion, surpassing analyst expectations of $3.28 billion.

Marvell Technology, on the other hand, faced a substantial setback, with a YTD decline of 32.1%. The semiconductor company closed at $80.37, marking a -1.68% move from the prior day. The investment community will be closely monitoring the company's upcoming earnings report, expected to show an EPS of $0.67, a 123.33% rise compared to the previous year [3].

Amazon's 6.6% decline is attributed to a range of factors, including increased competition and market fluctuations. Mondelez International's 1.8% gain is likely driven by positive market sentiment and strong performance in the food and beverage sector.

The Nasdaq 100 index has seen varied performance throughout the year, with several key players experiencing significant fluctuations. Investors are advised to stay informed about the latest developments and earnings reports to make informed investment decisions.

References:
[1] https://www.marketbeat.com/instant-alerts/filing-beacon-investment-advisory-services-inc-raises-position-in-regeneron-pharmaceuticals-inc-nasdaqregn-2025-07-22/
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TT1PY:0-regeneron-pharmaceuticals-inc-reports-results-for-the-quarter-ended-june-30-earnings-summary/
[3] https://www.nasdaq.com/articles/marvell-technology-mrvl-dips-more-broader-market-what-you-should-know